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Summary 
There has been increasing evidence which suggests that abnormal expression of the estrogen receptor (ER) 
protein in nonmalignant breast tissue may be important in the carcinogenic process. To examine the effects of 
ER expression in immortalized nonmalignant mammary epithelial cells, an expression vector containing hu- 
man ER cDNA was transfected into the ER negative human breast Cells, MCF10A. Characterization of a 
clone stably expressing ER, 139B6, provided evidence for the regulated synthesis of a functional ER capable 
of binding estradiol-17[3 (E2) and undergoing processing. Expression of the ER gene did not enable E 2 to 
stimulate endogenous genes [progesterone receptor (PgR), pS2, cathepsin D and TGF~] which normally 
respond to estrogens in breast cancer cells. The ER in 139B6 cells was, however, capable of inducing expres- 
sion of an ERE-regulated reporter gene, indicating its ability to interact with transcriptional machinery. Fur- 
thermore, cultures in log growth displayed a slight increase in doubling time in the presence of E 2. These 
results indicate that ER expression alone is not sufficient to induce a transformed phenotype. Thus, the 139B6 
cell line should provide a new model for determining what additional changes lead to increased growth poten- 
tial in response to E 2 and for exploring how E 2 itself may help bring about changes leading to progression of 
preneoplastic breast epithelial cells. 
Introduction 
Although it has not been possible to determine the 
direct role of estradiol-17[3 (E2) in breast cancer, ex- 
cessive estrogen exposure has been implicated in 
the induction of breast cancer for over 100 years [1]. 
E> which exerts its effects by binding to an intracel- 
lular receptor to induce estrogen responsive genes, 
is thought to be mitogenic for both breast tumors 
and normal breast tissue. However, the regulation 
of growth by this hormone differs. In normal breast, 
E 2 exerts its effects in a carefully regulated manner, 
as opposed to the uncontrolled growth observed in 
E2-dependent breast cancer cells [2]. Expression of 
the estrogen receptor (ER) in normal breast also 
differs from that observed in breast tumors. Under 
nonlactating conditions, normal breast does not ex- 
press ER in abundance. Roughly 7% of the total ep- 
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ithelial cell population of breast tissue biopsies con- 
tain ER, while approximately 75% of breast tumor 
biopsies express significant levels of ER [3, 4]. Fur- 
thermore, a recent study by Khan et al. found a 
strong association between ER positivity of benign 
breast epithelium and breast cancer risk [5]. These 
observations imply that ER itself may be important 
in the carcinogenic process. 
It has long been believed that development of 
cancer is a multistep process, arising from the accu- 
mulation of multiple genetic and epigenetic alter- 
ations [6, 7]. The properties of breast cancer cells in 
culture have been well studied as a number of 
breast epithelial tumor cell lines (MCF-7, ZR-75, 
and T47D) have been established. Primary cultures 
of normal breast epithelium have proven more dif- 
ficult to study long term, as these cultures eventu- 
ally undergo senescence. Established normal im- 
mortalized breast epithelial cell lines are rare and 
have been difficult to establish without chemical or 
viral intervention [8-15]. The recent development 
of the spontaneously immortalized MCF10 cell 
lines by Soule and coworkers [9] has thus provided a 
unique model system in which to examine the pro- 
gression between immortalization and transforma- 
tion of breast epithelial cells. 
The MCF10 lines arose spontaneously from mor- 
tal ceils cultured from breast tissue of a woman with 
fibrocystic disease. Several of these lines (MCF10A, 
10E etc.) have survived in culture for more than 7 
years [9]. The MCF10A cell line is pseudodiploid 
with minimal chromosomal rearrangements and 
exhibits many of the properties of a nonmalignant 
cell line, including the inability to induce tumors in 
athymic mice, even in the presence of estrogen [9]. 
Most important for this study, MCF10A cells, like 
most normal breast epithelial cells, do not express 
ER mRNA or protein despite having an apparently 
unaltered gene [9; see below]. 
The results of previous studies investigating the 
introduction of ER into cell lines have been varied. 
The transient expression of a functional ER has 
been demonstrated after transfection of yeast, He- 
La cells and chicken embryo fibroblasts [16-18]. 
Stable expression of transfected ER genes has also 
been obtained in a number of cultures including the 
Chinese hamster ovary (CHO) [19], HeLa [20], Syr- 
ian hamster uterine myocyte [21], and osteosarco- 
ma ROS17/2.8 cell lines [22]. ER genes have also 
been transfected into both immortal (184B5) and 
ER negative tumorigenic (21MT-2 and MDA- 
MB-231) breast cell lines [2, 23, 24]. These studies 
indicate that expression of functional ER in trans- 
fected breast cell lines leads to stimulation of some 
E 2 regulated genes upon exposure to E 2. Rather 
than being stimulatory, however, cell proliferation 
is inhibited when cultures are exposed to E 2 [2, 23]. 
In an effort to better understand the role of E 2 and 
ER in the early stages of breast cancer develop- 
ment, we have selected and studied MCF10A cells 
stably expressing ER after transfection with a mam- 
malian expression vector containing ER cDNA. 
Materials and methods  
Cell culture 
The MCF10A1 cell line (obtained from Dr. Jose 
Russo, Fox Chase Cancer Center, Philadelphia, 
PA), as well as all transfectants, were maintained in 
optimal growth media: a phenol red- and HEPES- 
free custom formulation of DMEM: F12 media (1:1; 
Gibco, Gaithersburg, MD; formula number 90- 
5149-EG) supplemented with 1.05 mM calcium 
chloride (Sigma, St. Louis, MO), 5% equine serum 
(Gibco), cholera enterotoxin (100 ng/ml; ICN Bio- 
medicals, Cleveland, OH), insulin (10 gg/ml; Sig- 
ma), cortisol (1.4x 10-6M; Sigma), epidermal 
growth factor (EGF; 20 ng/ml; Gibco), and anti- 
biotics (penicillin, 100 U/ml; streptomycin, 100 gg/ 
ml; amphotericin, 0.25 gg/ml, and gentamicin sul- 
fate, 0.5 btg/ml; all from Sigma). For experiments, 
cultures were exposed to 10 -8 M E 2 (in ethanol) for 
the indicated times in media containing dextran 
coated charcoal (DCC) stripped serum (to mini- 
mize E 2 content; 25) while control cells received 
ethanol vehicle in this medium. 
Construction o f  pH~-Apr-l-neo-ERwt (Fig. 1) 
Wildtype ER cDNA (ERwt; a gift ofR Chambon 26) 
was subcloned into the BamHI site of the pHI3- 
actinpromoer 
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Fig. 1. The expression vector pH~i-Aprl-neo-ERwt. The 1.9 kb 
EcoRI ER cDNA fragment [26] was inserted into the BamHI 
polylinker site of the pH~-Aprl-neo vector. This vector contains 
3 kb of the human 13-actin 5' flanking sequence plus 78 bp of 5' 
untranslated region (UTR), 832 bp of intervening sequence 1 
(IVS1), SV40 polyadenylation signal (SV40 poly A), and the re- 
sistant genes for ampicillin (Ampr) and neomycin (SV2-neo; 27). 
Apr-l-neo vector (a gift ofT. Trevor 27). Briefly, the 
1.9 kb EcoRI ER cDNA fragment (cloned into the 
EcoRI site of the pSG5 vector; 26, 28) was ligated to 
EcoRI-BamHI adaptors (synthesized by Biosyn- 
thesis, Inc., Denton, TX). Unreacted adaptors were 
separated on a Sepharose CL-4B (Sigma) column 
and the insert was subcloned into the BamHI site of 
the pH~-Apr-l-neo vector [29, 30]. 
Transfection of  MCFIOA cells pH~-Apr-l-neo-ERw, 
pHl3-Apr-l-neo-ERwt was transfected into 
MCF-10A cells using a modified version of the calci- 
um phosphate mediated transfection procedure 
[29]. This mammalian expression vector contains 
3 kb of the human ~3-actin 5' flanking sequence 
along with the genes for ampicillin (13-1actamase) 
and neomycin (aminoglycoside phosphotransfe- 
rase) resistance [27]. Ten gg of plasmid DNA were 
used per 60 mm culture dish of cells (roughly 60% 
confluent) and the pH of this transfection solution 
was adjusted to 7.0, a critical step for optimum 
transfection efficiency. Calcium chloride (2 M) was 
added slowly to the mixture (final concentration of 
125 mM) and allowed to precipitate for 30 minutes 
at room temperature prior to addition to the cells. 
The mixture was allowed to incubate on the cells for 
5 hours at 37 ° C in a humidified 5% CO 2 incubator. 
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The medium was then removed, the cells washed 
once with phosphate buffered saline (PBS), and the 
cells glycerol-shocked with 20 % glycerol for 4 min- 
utes to increase the efficiency of transfection. The 
cells were rinsed twice with PBS and allowed to 
grow in complete medium for 72 hours. The selec- 
tive agent, Geneticin (G418 Sulfate; Gibco) was 
then added at a concentration of 300 gg/ml of media 
and cells grown for at least 3 weeks before individu- 
al clones were chosen. 
Northern analysis 
PolyA mRNA was extracted, separated by agarose 
gel electrophoresis, and transferred to Nytran 
membranes (Schleicher and Schuell, Keene, NH) 
according to previously published procedures [31, 
32]. Membranes were probed with the following 35S 
radiolabeled cDNAs: ER (HEGO; a gift of R 
Chambon); cathepsin D (pNR100; a gift from B. 
Westley); pS2 (a gift from R Chambon); TGF-~ 
(sp65C17N3; a gift of R. Derynck); and progester- 
one receptor (PgR; pGR7ZF/EBR14A-1 kb of the 
bovine steroid binding domain, a gift of D. Skafar). 
Membranes were subsequently probed with 35S ra- 
diolabeled 36B4 (a gift of P. Chambon) or human 
(~-tubulin (gift of T. Trevor) to evaluate integrity of 
mRNAs and to provide an internal reference for 
variations in the amount of RNA loaded in each 
lane. Hybridization and membrane washing were 
carried out according to previously published pro- 
cedures [32]. For each experiment, approximately 
2.0 × 10  7 cpms of the probe (specific activity of ap- 
proximately 109 cpm/gg) were added to the hybrid- 
ization buffer after denaturation at 95°C for 10 
minutes. Results were quantitated with a Molecular 
Dynamics densitometer employing Imagequant TM 
software (Sunnyvale, CA). 
Immunochemical detection of  ER 
Cells were plated in 8 well tissue culture chamber 
slides (Nunc, Inc., Naperville, IL) at approximately 
50,000 cells per well and grown to 50% confluency 
(roughly 100,000 cells per well) in a 37 ° C humid- 
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ified C O  2 environment.  Immunocytochemical de- 
tection of E R  was performed using the Abbot t  ER- 
ICA Monoclonal Kit (Abbott  Park, IL) following 
procedure outlined by the manufacturer.  The pres- 
ence of E R  was detected using diaminobenzi- 
dine-4HC1 as a substrate. Only cells with a darkly 
stained (brown) nucleus were considered positive 
for ER. Staining of transfectant cell lines was com- 
pared to that obtained with MCF-7 cells, which ex- 
press high levels of ER. 
Determination of levels of  ER 
The levels of ER  were measured both by ligand 
binding and by enzyme immunoassay methods. For 
ligand binding, the classic dextran coated charcoal 
binding assay developed by Davies et aL [33] was 
used. All experiments were carried out at 4 ° C. 
Cells were grown to approximately 60% confluency 
(1 × 10 7 cells) in 75 cm 2 flasks. Cells from 4 flasks 
were suspended in 4.5 ml ice cold TE buffer pH 7.5 
plus i mM dithiothreitol (DTT),  transferred to a 
dounce homogenizer,  and homogenized with 15 
strokes of a glass pestle on ice. The homogenate  was 
then centrifuged at 100,000 g for 60 minutes at 4 ° C. 
The pellets were stored at - 20 ° C for DNA quanti- 
tation. Aliquots of cytosolic extract (0.4 ml) were 
incubated with tritiated Ez(2,4,6-3H)-E2, 96 Ci/ 
mmol, NEN DuPont,  Boston, MA] over a concen- 
tration range of 0.2-1.77 nM with and without a 200 
fold excess of unlabeled E z. This mixture was al- 
lowed to incubate overnight at 4 ° C. Dextran coat- 
ed charcoal solution (0.4 ml-DCC; 0.5% charcoal, 
0.003 mM dextran, 1 mM D T T  in 1 × TE pH 7.4) 
was added to each sample, the tubes mixed and in- 
cubated on ice for 15 minutes. Upon centrifugation 
at 2000 g for 15 minutes, aliquots (250 gl) of each 
sample were added to 2 ml ethanol and 10 ml scintil- 
lation fluid (Scintiverse E; Fisher Scientific, Pitts- 
burg, PA), and the radioactivity determined in a 
Packard Tricarb 4530 scintillation counter. Mathe- 
matical t reatment of the results were patterned af- 
ter Davies [33] and Scatchard [34]. 
For the enzyme immunoassay, cells were grown 
to 50% confluence in 75 cm 2 flasks; 10 8 M E 2 was 
added for 0 (ethanol vehicle), 1, 3, 6 or 24 hours. 
Cells were harvested and cytosolic and nuclear ex- 
tracts were prepared as previously described [35, 
36]. ER  content was measured in both nuclear and 
cytosolic extracts following protocols previously 
described [35]. 
Quantitation of DNA 
The amount of D N A  in each of the pellets described 
above was measured by a modified method of Bur- 
ton [37] as previously described [35]. 
Growth curves 
MCF10 cells and their derivatives were seeded at 
densities of 3 x 104 to 1 x 105 in 25 cm 2 culture flasks 
containing experimental medium (optimal growth 
medium minus EGF, insulin, cortisol, and cholera 
enterotoxin) supplemented with 5% equine serum 
and antibiotics. Sufficient flasks were prepared to 
provide three measurements of cell number  at each 
time point during indicated treatments. One day 
later, the medium was changed on alternate days 
until cells approached confluence, at which point 
the media was changed daily. 
Growth of cultures was monitored utilizing the 
procedures described by Weise et aI. [25]. Briefly, 
cells were allowed to swell in a hypotonic H EP ES  
buffer (2 ml/25 cm2; 0.01 M HEPES,  0.015 M mag- 
nesium chloride) for 10 minutes at room temper- 
ature. The cells were then lysed by incubating with 
detergent [200~tl/T25 of 0.13 ethylhexadecyldi- 
methylammonium bromide (Eastman Kodak, 
Rochester,  NY) in 3% v/v of acetic acid (Fisher)]. 
The resulting nuclear suspension was diluted to ap- 
propriate volumes with filtered saline and counted 
with a Coulter Counter  [38]. Cell number  was de- 
termined at a minimum of 9 time points to establish 
a growth curve. 
Transfection of the 139B6 and 139-2-8 cell lines for 
transient CAT expression assays 
Eighteen to twenty-four hours prior to transfection, 
7 kb  
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Fig. 2. Representative Northern blot of mRNA from selected clones of the MCF10A cell line transfected with pH~-Apr-l-neo-ER,~ 
probed with radiolabeled 35S ER cDNA. Blots were subsequently washed and reprobed with 35S radiolabeled c~-tubulin cDNA to control 
for variations in RNA loading. Lane 1 represents mRNA extracted from the human breast cancer cell line, MCF-7. Note the expected 7 kb 
endogenous ER mRNA. Lanes 2 and 3 represent mRNAs extracted from parental MCF10A cells. Lanes 4 and 5 represent mRNAs from a 
pHl3-Aprl-neo vector transfected MCFIOA cell line, 139-2-8. Lanes 6 through 15 represent mRNAs extracted from pH[3-Aprl-neo-ERwt 
transfected MCF10A cell lines. Positive clones expressed ER mRNA of 1.9 kb. Lanes 12 and 13 represent mRNA extracted from 139B6 
cultures. 
cells were plated at 1 x 10 6 cells per  60 m m  tissue cul- 
ture dish. Three  hours prior to transfection, the me- 
dium was replaced with DMEM/F12 medium ad- 
justed to p H  7.3-7.4. Cultures were transfected with 
an ER-responsive CAT repor ter  gene using the 
strontium phosphate  procedure described by Brash 
et al. [39] modified by incubating the cells with 10 gg 
of D N A  (JA12 plasmid [40]) per  dish for 4 hours 
followed by a 4 minute incubation with 20% glyce- 
rol. The cells were then treated with 10SM E2, 
107M ICI  164,384, or ethanol vehicle for 48-72 
hours. Separate cultures were also transfected with 
RSV-CAT to moni tor  transfection efficiency [40]. 
C A T  assays 
CAT assays were carried out as described by Gor- 
man [41]. Predetermined amounts of supernatant  
protein f rom each sample (5 gg for the 139B6 cell 
line and 75 gg for the 139-2-8 control line) were add- 
ed to reaction mixtures with 0.1 pCi of 14C-chloram- 
phenicol (40-60 mCi/mmol;  ICN radiochemicals, 
Irvine, CA). The reaction was incubated for 2 hours 
at 37 ° C. Acetylated chloramphenicol was separat-  
ed by thin-layer chromatography and visualized by 
autoradiography. Spots were excised and radiolabel 
quanti tated by liquid scintillation counting. Protein 
concentrations were determined utilizing the 
Pierce BSA assay kit (Rockford,  IL). 
Results 
pH[3-Apr-l-neo-ERwt was transfected into the 
MCF10A cell line. The parent  vector (pH~-Apr-1- 
neo) was also transfected into MCF10A cells to 
serve as a control. After  3 weeks exposure to 
300 gg/ml Geneticin, 10-15 resistant clones f rom 
each transfection were isolated and expanded. 
m R N A  was extracted f rom randomly selected 
Geneticin resistant clones and tested for expression 
of E R  mRNA.  A representative Nor thern  blot of 
m R N A s  from several clones is shown in Fig. 2. Ap-  
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proximately 50% of the selected pH[3-Apr-l-neo- 
ERwt-transfected clones expressed a 1.9 kb E R  
mRNA: no clones of the MCF10A cell line trans- 
fected with the control plasmid (MCF10A-neo) ex- 
pressed this mRNA (Fig. 2). Fur thermore  none of 
the selected clones expressed the 7 kb endogenous 
ER  mRNA. Restriction analysis of genomic DNA 
extracted from these clones also indicated the pres- 
ence of the expected 1.9 kb fragment upon diges- 
tion with either BamHI or EcoRI.  This fragment 
was not detected in the parental MCF10A cell line 
or MCF10A cells transfected with the control plas- 
mid (data not shown). 
Several clones from each transfection were test- 
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Fig. 3. Immunocytochemical detection of ER protein in 139B6 and 139-2-8 cell lines. Cultures were stained for ER protein using Abbott 's 
ER-ICA kit. Darkly stained nuclei indicate the presence of ER. Cells were photographed using a phase contrast microscope. A) Sub- 
confluent 139B6 cultures. B) 139-2-8 cultures. C) Postconfluent 139B6 cultures. 
ed for expression of ER protein. MCF-7 cells, which 
express high levels of ER, were used as a positive 
control and the parent MCF10A cells were used as a 
negative control. ER positive cells displayed an in- 
tense nuclear staining (Fig. 3a). Cells transfected 
with the parent vector alone (line 139-2-8) did not 
express ER (Fig. 3b). Faint background staining 
throughout the cell was common to all cells exam- 
ined. One clone, 139B6, which expressed ER abun- 
dantly (70-90% of the cells) was selected for study. 
Further immunocytochemical analysis of the 139B6 
cell line revealed a loss of ER expression when cells 
reached confluence (Fig. 3c). More than 80% of 
cells expressed abundant ER until the density of the 
cultures reached approximately 80% confluence. 
After this point, both the proportion of ER positive 
cells and the intensity of nuclear staining decreased 
dramatically (Fig. 3c). Thus, it appears these cells 
only express ER during log phase growth. Analysis 
of both the parent MCF10A and the control 139-2-8 
cell lines failed to detect ER expression at any level 
of confluence examined (Fig. 3b; data not shown). 
All subsequent experiments were performed on 
subconfluent cultures to ensure expression of ER. 
Western analysis of nuclear lysates from the 139B6 
cell line detected the presence of anti-ER reactive 
protein of approximately 67 kD, the expected 
molecular weight for ER (data not shown). 
The levels of ER in the 139B6 cell line were mea- 
sured both by ligand binding and by enzyme immu- 
noassay methods. Cytosolic extracts of cultures 
were analyzed for their ER content by the classical 
DCC binding assay. Figure 4 depicts saturation 
curves obtained for each of these cell lines at 4 ° C. 
Both the MCF-7 (Fig. 4a) and 139B6 (Fig. 4c) cells 
contained significant levels of ER, whereas cytosol- 
ic extracts of the parent MCF10A (Fig. 4b) and vec- 
tor transfected 139-2-8 (Fig. 4d) cells contained no 
ER detectable by this assay. Scatchard analysis 
yielded a dissociation constant of 1.51 x 10 -l° M for 
the ER expressed in the 139B6 cells, comparable to 
that obtained for the ER in MCF-7 cells (1.41 x 
10 -l° M; data not shown). ER levels were also com- 
parable for the two cell lines, yielding 1.24 fmoles 
ER/gg of DNA for the 139B6 cell line and 
0.8 fmoles ER/gg of DNA for MCF-7 cells (average 
range is 1-4 fmoles ER/gg of DNA for MCF-7 cells; 
L. Polin, unpublished results; data not shown). 
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Fig. 4. Detection of E 2 binding sites in cytosolic extracts of 
MCF-7, MCF10A, and transfected MCF10A cells. Saturation 
binding data of3H E 2 binding to cytosolic extract of: A) the posi- 
tive control MCF-7; B) the parent cell line MCF10A; C) the ER 
transfected MCF10A clone 139B6; and D) the mock transfected 
MCF10A clone 139-2-8. Cytosolic extracts from MCF-7, 
MCF10A, 139B6, and 139-2-8 cells were incubated for 24 hours at 
4 ° C with a range of 3H E 2 concentrations in the presence (non- 
specific binding depicted by II) and absence (total binding de- 
picted by @) of unlabeled E 2 utilizing procedures described in 
Materials and methods. Specific binding was calculated as the 
difference between total and nonspecific binding. These values 
were used for Scatchard analysis (data not shown). 
Hours exposed to 10 -8 M E 2 
Fig. 5. Nuclear binding of the ER complex in the 139B6 cell line. 
Subconfluent cultures were pulsed with 10 -s M E 2 for 0,1, 3, 6 and 
24 hours prior to harvesting. Cytosolic (O) and nuclear ([~) ex- 
tracts were prepared from separate flasks utilizing the proce- 
dures described in Materials and methods. ER levels were de- 
tected with monoclonal antibodies using Abbott's ER-EIA kit. 
Points indicate the average of two determinations. Experimental 
results were compared to results with extracts from the ER con- 
taining MCF-7 cell line (data not shown). 
Levels of  E R  were also measured  by E R - e n z y m e  
immunoassay  ( E R - E I A ) .  Exposure  of  subcon-  
fluent cultures of  139B6 cells to E 2 b rough t  about  
classic tight nuclear  binding of  the cytosolic recep- 
tor complex,  reaching a max imum at 3 hours,  and 
leaving little receptor  in the 100,000 g cytosolic su- 
pe rna tan t  (Fig. 5). Total E R ,  represented  by its nu- 
clear form, decreased by approximate ly  50% after a 
6 hour  exposure  of  cells to E 2 (Fig. 5). A maximal  
value of  2.46 fmoles of  E R / g g  of  D N A  was deter- 
mined  for the 139B6 cell line, which was comparab le  
to maximal  levels ob ta ined  for the samples extract- 
ed f rom MCF-7 cultures (data not  shown; approxi-  
mate ly  4 fmoles of  E R / g g  of  D N A ) .  
Initial growth character izat ions were pe r fo rmed  
on bo th  E R  and vector  t ransfected M C F 1 0 A  cells. 
Table 1 summarizes  doubl ing times of  cultures after 
t r ea tment  with appropr ia te  media.  Overall ,  the 
doubl ing times of  the ER- t rans fec ted  cell line were  
longer  than those of  the vector- t ransfected cell line 
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(Table 1). Comparison of the saturation densities 
for both cell lines in optimal growth media without 
E 2 indicated a slightly higher saturation density for 
vector-transfected 139-2-8 cells (480,000/cm 2) than 
for 139B6 cells (400,000/cm2). The growth rate of 
the 139-2-8 cells remained unchanged upon addi- 
tion of 10 .8 M E 2 to the growth medium (doubling 
times of 18.1 hours for control growth medium and 
18.5 hours upon addition of E2). This data is consis- 
tent with our results and those previously reported 
by Soule [9] with the parental cell line MCF10A, 
where no effect on growth rate was observed upon 
the addition of E 2. Addition of E 2 consistently in- 
creased the doubling time of the 139B6 cell line by 
15 %. However, there was no statistical difference in 
growth rates (Table 1). 
Withdrawal of EGF from cultures of both 139-2-8 
and 139B6 ceils resulted in an increased doubling 
time and lower saturation density, indicating that 
both cell lines, like the parental MCF10A cells, still 
require EGF for optimal growth (Table 1). Addi- 
tion of E 2 to EGF-depleted media had no effect on 
growth of these cells (Table 1). Withdrawal of corti- 
sol from 139-2-8 and 139B6 cultures resulted in an 
increase in doubling times (24.7 and 30.6 hours re- 
spectively; Table 1), indicating that transfected cul- 
tures were still dependent on cortisol for optimal 
growth. Addition of E 2 to cortisol depleted 139B6 
cultures resulted in the doubling time increasing 
from 30.6 to 37.4 hours (Table 1), while no differ- 
ence in doubling time was observed in the vector 
transfected 139-2-8 cell line. Under these condi- 
tions, the appearance of the 139B6 cells were al- 
tered, with cells becoming enlarged and containing 
many vacuoles (data not shown). This suggests that 
the addition of E 2 to 139B6 cells growing in cortisol 
depleted medium was detrimental. 
To determine if the ER expressed in the 139B6 
cultures could induce endogenous E 2 responsive 
genes in cultures, the effect of E 2 on levels of pS2, 
cathepsin D, PgR and TGF~ mRNAs was examin- 
ed. No expression of the 0.6 kb pS2 mRNA was ob- 
served in any of the MCF10A cultures examined 
(including the parent MCF10A, 139-2-8 and 139B6 
cell lines; data not shown). Both the 2.1 kb cathep- 
sin D and the 4.5 kb TGFo~ mRNAs were detected 
in all three MCF10A cell lines. However no induc- 
tion of either mRNA was observed upon addition 
of E 2 (Fig. 6). Interestingly, PgR mRNA was also 
detected in the parental and transfected MCF10A 
cells but did not increase in level upon E 2 treatment 
(data not shown). PgR protein, however, was not 
detected in any of these cultures by ligand binding 
or Western analysis (data not shown). 
The findings that the ER in the 139B6 underwent 
processing upon exposure to E 2 and that E 2 could 
alter growth of 139B6 cells but not 139-2-8 cells sug- 
gested that 139B6 cells are expressing a functional 
ER. However, since none of the endogenous estro- 
gen responsive genes examined responded to add- 
ed E 2 with increased activity, further evidence of re- 
ceptor function was necessary. For this purpose 
Table 1. Doubling times of 139B6 (ER +) and 139-2-8 (ER - )  cells 
Treatment  139B6 doubling time ~ (n) ~ 139-2-8 doubling time ~ (n) I~ 
Control c 21.6 + 5.1 (3) 18.1 + 0.17 (2) 
- HC c 30.6 + 3.8 (2) 24.7 (1) 
- E G F  c 35.5 (1) 32.9 (1) 
- HC, + E2 ~ 37.4 + 10.4 (2) 26.0 (1) 
- EGF, + Ez c 37.5 (1) 30.6 (1) 
Control,  + Ez ~ 24.8 + 4.25 (3) 18.5 + 0.81 (2) 
a Doubl ing time was calculated during log phase growth of cells using the following equation: (t) [log 2/log (B/A)] = D, where t is the time 
of growth in hours; B represents  cell number  at harvest  (or confluency); A represents  number  of  cells seeded; and D represents  the 
doubling time (H. Soule, personal  communications) .  See Materials and methods  for experimental  design. 
b Number  in parentheses  corresponds to the number  of exper iments  performed. Each exper iment  consists of three flasks per t ime point. 
c Control media consisted of DMEM/F12 supplemented  with 5% DCC stripped horse serum, cortisol (HC), cholera toxin, insulin, E G F  
(epidermal growth factor), and antibiotics as described in the Materials and methods.  The  following abbreviations were used for varia- 
tions in media: - HC, control media  without cortisol; - EGF, control media without EGF; + E 2 indicated media with 10 .8 M E 2. 
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TGFc~ 
Cath D 
LANE 1 2 3 4 
Fig. 6. Effect of 10 -8 M E 2 o n  levels of cathepsin D and TGFa 
mRNA in the 139B6 cells, mRNAs from cultures pulsed with eth- 
anol vehicle are shown in lanes I and 2. mRNAs from cells pulsed 
with 10 .8 M E z are shown in lanes 3 and 4. Cultures were treated 
with E 2 for 24 hours and mRNA was harvested as described in 
the Materials and methods. Northerns were hybridized with 35S- 
radiolabeled cDNA probes for cathepsin D and TGFc~. Mem- 
branes were subsequently probed with 35S radiolabeled 36B4 
cDNA for standardization. Autoradiographs were scanned uti- 
lizing a densitometer and quantitated. Blots were then corrected 
for loading error using densitometric values for 36B4 before cal- 
culation of fold increase. No change in induction of either 
mRNA was observed after correction was made. 
139B6 and 139-2-8 cells were transfected with the 
JA12 plasmid, which contains a CAT gene immedi-  
ately downstream of a regulatory region containing 
two E R E s  (one consensus and one mutant)  and a 
minimal thymidine kinase p romote r  [40]. CAT ex- 
pression in MCF-7 cells transfected with JA12 can 
be induced up to 43 fold in the presence of 10 -11 M E 2 
[40]. Treatment  with E 2 stimulated transient CAT 
expression in JA12-transfected 139B6 cells more  
than 30 fold as compared  to cells t reated with vehi- 
cle alone (ethanol) or to JA12-transfected 139-2-8 
cells (Fig. 7). No induction of CAT activity was ob- 
served in 139B6 cells t reated with the antiestrogen 
ICI  164,384. 
Discussion 
The recent development  of the MCF10 cell lines 
provides new opportunities to study the progres- 
sion of breast  cancer. These cultures are the only 
nonmalignant  immortalized human breast  cell lines 
developed thus far without chemical or viral inter- 
vention. In contrast to breast  tumors and breast  
cancer cell lines which express ER,  the MCF10A 
cell line, like normal  breast  tissue, does not express 
significant levels of ER. Our  results clearly demon-  
strate that functional E R  can be expressed in 
MCF10A cells after transfection with a vector con- 
taining ERwt cDNA under control of a ~3-actin pro- 
moter.  Transfected, but not parental  cells, contain 
the expected 1.9 kb mRNA.  Depending on the 
clone and the conditions of culture, E R  protein may 
be detected in 10-95 % of cells. This E R  is normal  by 
four criteria: 1) the ability of the expressed E R  to be 
recognized by specific monoclonal  antibodies, 2) 
the ability of the expressed E R  to bind E2, 3) the 
ability of expressed E R  to undergo 'processing'  (re- 
duction in level of nuclear E R  during continuous 
exposure to E 2 [36, 42-44]) and 4) the ability of the 
expressed E R  to activate expression of an ER-re-  
sponsive CAT repor ter  gene. 
As demonstra ted  by exposing cells f rom the E R  
(+) clone 139B6 to E 2, MCF10A cells can tolerate 
expression of E R  at the same level as is found in 
MCF-7 cells with little or no effect on growth or 
morphology. This contrasts with several reports  of 
detr imental  effects or severe inhibition of growth 
occurring when normal  or tumor-derived breast  
cells overexpressing E R  genes are exposed to E 2 [2, 
19, 23]. While we did observe a consistent increase 
in doubling time of approximately 15 % when 139B6 
cells were exposed to E 2, this response was minimal 
when compared  to growth inhibition described by 
others [2, 19, 23]. It  is likely that this difference in 
E R  expression resulted f rom the use of a p romoter  
of modera te  strength, the [3-actin promoter ,  rather  
than strong promoters  such as Rous sarcoma virus 
(RSV), cytomegalovirus (CMV), or metallothio- 
nien. The level of E R  in 139B6 cells, which had the 
highest expression of E R  in all transfectants isolat- 
ed in this study, was approximately 9000 receptors 
per  cell (average receptor  content of MCF-7 cells is 
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Fig. 7. Induction of CAT activity by E 2 in JA12 transfected 139B6 and 139-2-8 cultures. A) Representative autoradiograph showing CAT 
activity in 139B6 cultures transiently transfected with the JA12 plasmid. CAT activity in protein lysates extracted from cultures treated 
with ethanol vehicle (lanes 1 and 2); IC1164,384 (lanes 3 and 4); and 10 .8 M E a. The substrate [14C]chloramphenicol is designated as I, while 
the products of the enzyme reaction, 1- and 3-acetylated [14C]chloramphenicol, are indicated by II and III respectively. The acetylated and 
nonacetylated forms of [~4C]chloramphenicol were excised and quantified by ~-scintillation counting. B) CAT activity values for the 
139B6 cell line represent an average of multiple determinations (n = 6-12) with standard deviations depicted by bars. CAT activity values 
for the 139-2-8 cell line are the average of two experiments. Ranges are depicted by bars. The JA12 plasmid contains a consensus and a 
mutated ERE upstream of a minimal thymidine kinase promoter fused to the chloramphenicol acetyltransferase (CAT) gene [40]. All 
details as described in Materials and methods. 
10,000-15,000 receptors per cell), while the level of 
ER in cells transfected with the ER gene under the 
control of the metallonthionien promoter ranged 
from 1,000,0005,000,000 ER per cell [19]. In addi- 
tion, in 139B6 cells, the regulation of ER gene ex- 
pression more closely mimics regulation by the en- 
dogenous ER promoter in MCF-7 cells, i.e. down- 
regulation as the cells enter stationary phase [44]. 
Although several groups have reported constitutive 
expression of ~-actin [27, 45, 46], in a number of cell 
types, [~-actin transcription is cell-cycle dependent 
[47, 48]. Thus, 139B6 cell growth may be less affect- 
ed by the presence of E 2 in the medium either be- 
cause the number of ER in the cell did not reach the 
level where transcriptional interference or squelch- 
ing occurs [19] or because ER expression ceases 
when the cells enter G o . 
Transfection and selection had no effect on the 
growth factor and hormone dependence of 139B6 
and 139-2-8 cells when compared to that of the par- 
ent line, MCF10A [9]. Removal of either EGF or 
cortisol from the growth medium still caused an in- 
crease in the doubling time of 139B6 and 139-2-8 
cells (Table 1). This indicates that both hormones 
are necessary for optimal growth of transfected and 
parental MCF10A cells. However, while E 2 had no 
effect on the growth or morphology of 139B6 cells 
growing in the absence of EGF, it was able to mod- 
ulate their growth rate when cells were cultured in 
the absence of cortisol. As MCF10 cultures appear 
to be more dependent on EGF for optimal growth 
than cortisol, the detrimental effect of removing 
EGF from the medium may mask the modest de- 
crease in growth rate upon addition of E 2. 
Finally, our findings that E 2 can induce a marked 
increase in transient CAT expression from an E 2 re- 
sponsive CAT reporter gene construct indicates 
that the ER produced in 139B6 cells is fully capable 
of interacting with the transcriptional machinery of 
the cell. Nevertheless, none of the endogenous E 2- 
responsive genes studied (pS2, cathepsin D, PgR, or 
TGF-~) were stimulated when 139B6 cells were 
treated with E 2. Zajchowski and Sager have previ- 
ously reported that pS2 transcription can be activa- 
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ted in ER(+) ER-transfected tumor derived cell 
lines but not in ER(+) ER-transfected cell lines de- 
rived by treating normal human mammary cells 
with benzo[a]pyrene (184B5: [24]). Further studies 
by this group involving somatic hybrids of the ER- 
transfected immortalized normal cell line and the 
ER+/pS2+ MCF-7 breast cancer cell line resulted in 
the abolishment of pS2 expression in these hybrid 
cells [49]. This phenomenon was also observed in 
somatic hybrids of the parental immortalized cell 
line and MCF-7 [49]. Moreover, these hybrid cells 
are suppressed in their tumorigenic ability, display- 
ing characteristics similar to the 'normal' parental 
cell line. This suggests the existence of a tumor sup- 
pressor gene product in normal epithelial cells 
which is not active in tumor cells [24, 49]. If a protein 
of this nature exists in normal breast cells, pS2 
mRNA expression would not be expected in 
MCF10A cells. Likewise, based on the results of 
Zajchowski and Sager, pS2 mRNA expression 
would not be expected in ER-transfected MCF10A 
cell. 
In contrast to results obtained from other groups, 
however, no detectable induction of cathepsin D, 
PgR or TGFa mRNAs by E 2 was observed in 139B6 
cultures, indicating that additional factors may play 
a role determining the response of these genes [20, 
49]. In the case of cathepsin D, failure to see an in- 
crease in mRNA levels in response to E 2 may simply 
indicate that transcription of the gene has already 
been fully induced by other growth factors present 
in media. Transcription of the cathepsin D gene is 
regulated by several growth factors including EGF 
and insulin, both of which are present in MCF10A 
growth medium [50]. No attempts were made to ex- 
amine the effect of E 2 on cathepsin D mRNA levels 
in cells grown in media which did not contain added 
growth factors because cell viability is dramatically 
reduced by their removal. However, this hypothesis 
is supported by earlier studies on E 2 induction of 
cathepsin D mRNA expression in MCF-7 cells. 
These studies showed that natural variations in hor- 
mone and growth factor content of sera often re- 
sulted in high levels of cathepsin D mRNA in cells 
grown in the absence of E 2 and reduced the magni- 
tude of subsequent response to E 2 addition [32]. 
Still a third factor may play a role. Although the 
level of ER falls rapidly after MCF-7 cells reach 
confluency, induction of accumulation of mRNAs 
from a number of Ee-responsive genes, including 
pS2, PgR, and TGFc~, is more efficient when E 2 is 
added to cultures as they enter confluency than 
when they are in the logarithmic stage of growth [31, 
32, 35, 51]. In the studies presented here, all experi- 
ments were performed with subconfluent cultures 
since ER was diminished in confluent 139B6 cells. 
Thus, it is possible that ER expression was turned 
off too early to allow optimal expression of endoge- 
nous Ee-responsive genes in the 139B6 cells. 
Although it is clear that regulation of ER tran- 
scription by the I]-actin promoter is likely to differ 
in several aspects from regulation by the endoge- 
nous ER promoter, the results presented here dem- 
onstrate that expression of functional ER in immor- 
talized breast epithelial cells is not sufficient to 
cause gross morphological and growth changes 
characteristic of breast tumor cells. Since MCF10A 
cells were derived from a patient with fibrocystic 
disease and are not tumorigenic in nude-beige mice 
[9], our results also suggest that if ER expression is 
to provide a growth advantage during the early 
stages of progression of proliferative breast disease, 
the cells must first have undergone some additional 
changes that allow their growth to be stimulated by 
E 2 rather than be unchanged or inhibited. Thus, the 
availability of ER(+) MCF10A cells should provide 
an excellent system for determining what addition- 
al changes lead to increased growth potential in re- 
sponse to E 2 and for exploring how E 2 itself may 
help to bring about changes leading to progression 
of preneoplastic breast epithelial cells. 
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